PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Outcomes in patients with relapsed/refractory (RR) AML are poor. We sought to investigate if CPX-531 in combination with venetoclax (CPX + VEN) was tolerable and effective in…
Outcomes in patients with relapsed/refractory (RR) AML are poor. We sought to investigate if CPX-531 in combination with venetoclax (CPX + VEN) was tolerable and effective in…
Evasion of apoptosis has been identified as one of the essential hallmarks of cancer. Inhibitor of apoptosis proteins (IAPs) are implicated in a host of…
Key Points. There is no approved class of agents beyond JAK inhibitors for treatment-resistant myelofibrosis; therefore, novel approaches are needed.LCL161
Speakers: Francesco Onida, Naveen Pemmaraju To the Editor Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, orphan hematologic malignancy char¬acterized by tumor cell clonal…
Published in Leukemia & Lymphoma (Ahead of Print, 2025)
ABSTRACT. Leukemic masses are a known complication in patients with hematologic malignancies. Here we present a case regarding a patient with recently diagnosed B-acute lymphoblastic…
Published in Leukemia & Lymphoma (Ahead of Print, 2025)
THE GREAT ELEPHANT MIGRATION COMES TO HERMANN PARK Credit: Houston First CorporationCredit: Tasha GorelCredit: Houston First CorporationCredit: Houston First CorporationCredit: Tasha GorelCredit: H…
